Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood.

Abstract:

BACKGROUND:Transfusion-associated Chagas' disease (TA-CD) is a worldwide problem. Measures adopted to prevent TA-CD include the clinical and serologic screening of blood donors and/or the inactivation of Trypanosoma cruzi present in collected blood, using gentian violet as the trypanocidal agent. This study investigated the efficacy of white cell-reduction filters in removing T. cruzi from infected blood. STUDY DESIGN AND METHODS:Human blood was contaminated with 2 or 150 T. cruzi parasites per mL and then left unfiltered or filtered with white cell-reduction filters that provided either 2, 3, or 6 log10 white cell removal. The efficacy of the parasite removal of these filters was evaluated by microscopic enumeration of active forms of T. cruzi both in vivo and in vitro. The in vivo experiments were done in Swiss mice that had been intraperitoneally inoculated with T. cruzi-infected human blood. The in vitro experiments were performed with fresh human blood that had been deliberately contaminated with T. cruzi. RESULTS:The number of parasites seen in mice inoculated with unfiltered blood containing 2 or 150 parasites per mL was significantly higher than the number of parasites seen in mice inoculated with blood from the same sample, but filtered with white cell-reduction filters providing 3 or 6 log10 white cell removal. Fifty to 70 percent of the mice given T. cruzi-infected (2 parasites/mL) filtered blood did not develop T. cruzi infection. In vitro, the use of white cell-reduction filters, providing 2, 3, or 6 log10 white cell removal, significantly reduced the number of parasites seen in culture. CONCLUSION:The present experimental data provide evidence that white cell-reduction filters are effective in reducing the number of parasites in T. cruzi-infected blood and that this efficacy depends, in part, on the concentration of parasites in the artificially infected blood. Properly designed clinical studies of known carriers of T. cruzi must be conducted to determine whether the use of white cell-reduction filters may be an alternative method of reducing the incidence of TA-CD.

journal_name

Transfusion

journal_title

Transfusion

authors

Moraes-Souza H,Bordin JO,Bardossy L,MacPherson DW,Blajchman MA

doi

10.1046/j.1537-2995.1995.35996029154.x

subject

Has Abstract

pub_date

1995-09-01 00:00:00

pages

723-6

issue

9

eissn

0041-1132

issn

1537-2995

journal_volume

35

pub_type

杂志文章
  • Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits.

    abstract:BACKGROUND:Endothelial cells (ECs) play a pivotal role in the allogeneic immune response upon transplantation. Semaphorin 3A (Sema3A) was implicated in the modulation of EC growth, but its effects on immunogenicity were not previously investigated. STUDY DESIGN AND METHODS:ECs were transduced with a lentiviral vector ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.12631

    authors: Schlahsa L,Zhang H,Battermann A,Verboom M,Immenschuh S,Eiz-Vesper B,Stripecke R,Engelmann K,Blasczyk R,Figueiredo C

    更新日期:2014-08-01 00:00:00

  • A 'new' high frequency antigen Era.

    abstract::Three examples of an antibody defining a 'new' high frequency red blood cell antigen, Era, are described. Family studies show Era to be inherited, but the mode of inheritance may not be straightforward. ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1982.22382224938.x

    authors: Daniels GL,Judd WJ,Moore BP,Neitzer G,Ouellet P,Plantos M,Verrette S

    更新日期:1982-05-01 00:00:00

  • A comprehensive program to minimize platelet outdating.

    abstract:BACKGROUND:Platelet (PLT) transfusions are essential for patients who are bleeding or have an increased risk of bleeding due to a decreased number or abnormal function of circulating PLTs. A shelf life of 5 days for PLT products presents an inventory management challenge. In 2006, greater than 10% of apheresis PLTs mad...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2010.03039.x

    authors: Fuller AK,Uglik KM,Braine HG,King KE

    更新日期:2011-07-01 00:00:00

  • Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.

    abstract:BACKGROUND:Red blood cell (RBC) alloimmunization occurs at a high frequency in sickle cell anemia (SCA) despite serologic matching for Rh (C/c, E/e) and K antigens. RBC minor antigen genotyping allows for prediction of antigens and RH variants that may lead to alloimmunization. STUDY DESIGN AND METHODS:RBC antigen gen...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.14282

    authors: Yee MEM,Josephson CD,Winkler AM,Webb J,Luban NLC,Leong T,Stowell SR,Fasano RM

    更新日期:2017-11-01 00:00:00

  • Red blood cell use outside the operating theater: a prospective observational study with modeling of potential blood conservation during severe blood shortages.

    abstract:BACKGROUND:National guidance recommends planning for future blood shortages, but few studies have evaluated how reduced demand could be achieved acutely. STUDY DESIGN AND METHODS:A trained observer collected data concerning red blood cell (RBC) transfusion events outside the operating theater during 68 hours of blood ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2009.02244.x

    authors: Joseph BG,Hendry C,Walsh TS

    更新日期:2009-10-01 00:00:00

  • Analysis of apheresis content of progenitor cell collections from normal donors to whom granulocyte-colony-stimulating factor is administered.

    abstract:BACKGROUND:Allogeneic blood cell transplantation is a new alternative to bone marrow transplantation. Preliminary data suggest that granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells from normal donors can provide rapid hematopoietic engraftment without significant increases in tr...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1996.36111297091734.x

    authors: Weinthal JA,Nemunaitis JJ,Aston S,Magsamen MJ,Rosenfeld CS

    更新日期:1996-11-01 00:00:00

  • A rapid method for harvesting autologous red cells from patients with hemoglobin S disease.

    abstract::Red cells from patients with sickle cell disease (HbSS and HbSC) are more resistant to lysis in hypotonic NaCl solutions than normal (HbAA) red cells. Taking advantage of this inherent resistance to osmotic stress, patient red cells (HbSS or HbSC) were rapidly isolated from donor red cells (HbAA or HbAS) by washing wi...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1988.28188127945.x

    authors: Brown DJ

    更新日期:1988-01-01 00:00:00

  • Effects of colloidal resuscitation fluids on the neutrophil respiratory burst.

    abstract:BACKGROUND:Experimental studies have revealed that gelatin and HES produce increased neutrophil respiratory burst activity. It was investigated whether 3-percent gelatin (MW 35,000) and three types of 6-percent HES (MW 70,000; degree of substitution, 0.5; 200,000/0.5; 450,000/0.7) preparations can influence superoxide ...

    journal_title:Transfusion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1537-2995.2001.41081064.x

    authors: Jaeger K,Heine J,Ruschulte H,Jüttner B,Scheinichen D,Kuse ER,Piepenbrock S

    更新日期:2001-08-01 00:00:00

  • Effect of vitamin K administration on rate of warfarin reversal.

    abstract:BACKGROUND:Vitamin K is reported to begin reversing warfarin within 6 to 12 hours, but this may occur sooner. We sought to determine the rate of international normalized ratio (INR) reversal following vitamin K and relationships with dose, route, and baseline INR. METHODS:We evaluated adult patients receiving vitamin ...

    journal_title:Transfusion

    pub_type: 临床试验,杂志文章

    doi:10.1111/trf.15146

    authors: Polito NB,Kanouse E,Jones CMC,McCann M,Refaai MA,Acquisto NM

    更新日期:2019-04-01 00:00:00

  • Detecting failed WBC-reduction processes: computer simulations of intermittent and continuous process failure.

    abstract:BACKGROUND:By regulation, ongoing process control of WBC-reduced processes is performed on 1 percent of WBC-reduced components, typically four to five samples per month. However, prospective study of the power of this small sample has been difficult. Using computer-generated "residual WBC" distributions, sample size se...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.2000.40121427.x

    authors: Adams MR,Fisher DM,Dumont LJ,Dzik WH,Heaton WA

    更新日期:2000-12-01 00:00:00

  • A review of blood donor motivation and recruitment.

    abstract::Sixty English-language articles on the motivation and recruitment of blood donors and nondonors are reviewed and evaluated. Apparently researchers have been finding essentially the same results for approximately twenty years. Motivations to donate are: altruism/humanitarian, personal or family credit, social pressure,...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1977.17277151916.x

    authors: Oswalt RM

    更新日期:1977-03-01 00:00:00

  • Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV.

    abstract:BACKGROUND:In 1999, NAT of blood donations was implemented to detect "window-period" infections. Blood donors who have confirmed NAT results positive for the presence of HCV in the absence of anti-HCV are likely to have been recently infected. Of over 26.8 million donations tested between March 3, 1999, and March 31, 2...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2004.00623.x

    authors: Orton SL,Stramer SL,Dodd RY,Alter MJ

    更新日期:2004-02-01 00:00:00

  • Risk for malaria in United States donors deferred for travel to malaria-endemic areas.

    abstract:BACKGROUND:Deferral for travel to malaria-endemic areas excludes many blood donors in the United States. Most transfusion-transmitted malaria is associated with lengthy residence in malaria-endemic areas rather than routine travel. This study compares the impact of existing deferral requirements to the risk that a pres...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2009.02290.x

    authors: Spencer B,Steele W,Custer B,Kleinman S,Cable R,Wilkinson S,Wright D

    更新日期:2009-11-01 00:00:00

  • Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.

    abstract:BACKGROUND:Stress-enhanced platelet (PLT) storage lesions include increased glycolysis, discoid-to-sphere morphology change, and spontaneous PLT activation. It is not clear if reduction in glycolysis can alleviate storage lesion development. STUDY DESIGN AND METHODS:Apheresis PLT concentrates were exposed to 17.2 J/mL...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2005.00582.x

    authors: Li J,Goodrich L,Hansen E,Edrich R,Gampp D,Goodrich RP

    更新日期:2005-11-01 00:00:00

  • Heterogeneity of the phenotype Jk(a-b-) found in Japanese.

    abstract::Fourteen Jk(a-b-) persons were detected by testing 638,460 Osaka blood donors with an automated 2 M urea technique. Two of these 14 Jk(a-b-) samples were quite different from the hitherto reported Jk(a-b-) phenotype, and a family study showed that the mode of the inheritance was dominant. The red cell membranes of the...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1986.26386209377.x

    authors: Okubo Y,Yamaguchi H,Nagao N,Tomita T,Seno T,Tanaka M

    更新日期:1986-05-01 00:00:00

  • Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

    abstract:BACKGROUND:Much effort and resources have been devoted to programs that provide transfusion support for patients with sickle cell disease (SCD). The focus of many donor programs is to prevent alloimmunization by recruiting racially matched African American donors to limit the red blood cell (RBC) antigenic differences ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.13037

    authors: Karafin MS,Field JJ,Gottschall JL,Denomme GA

    更新日期:2015-06-01 00:00:00

  • Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.

    abstract:BACKGROUND:High-dose therapy with autologous stem cell support after standard dose induction is a promising approach for therapy of primary central nervous system lymphoma (PCNSL). High-dose methotrexate (HD-MTX) is a standard drug for induction of PCNSL; however, data about the capacity of HD-MTX plus granulocyte-colo...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2008.01927.x

    authors: Kiefer T,Krüger WH,Montemurro M,Schüler F,Hirt C,Pasold R,Niederwieser D,Schwenke M,Dölken G

    更新日期:2008-12-01 00:00:00

  • Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

    abstract:BACKGROUND:Congenital thrombotic thrombocytopenic purpura (TTP) may not be recognized until organ failure related to the microvascular thrombosis occurs. Kidney failure may be the initial presenting clinical feature. Kidney transplantation has been contraindicated because of the assumption that the continuing microvasc...

    journal_title:Transfusion

    pub_type:

    doi:10.1111/trf.14326

    authors: Fattah H,Kumar D,George JN,Massey HD,King AL,Friedman KD,Gupta G

    更新日期:2017-12-01 00:00:00

  • Modification of glutathione content in platelet concentrates by the use of acivicin.

    abstract:BACKGROUND:Intracellular glutathione declines progressively in platelet concentrates stored for transfusion, but little is known about the nature of this process. STUDY DESIGN AND METHODS:Acivicin, an irreversible inhibitor of gamma-glutamyl transpeptidase, was used to determine the fate of glutathione lost from plate...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1994.34594249055.x

    authors: Burch PT,Aman M,Burch JW

    更新日期:1994-05-01 00:00:00

  • The extension of 4 degrees C storage time of frozen-thawed red cells.

    abstract::Blood was drawn from volunteer donors and frozen using the high glycerin, mechanical freezing procedure accepted by the United States Navy. Subsequently, the units of blood were thawed and washed. Various anticoagulants were added, and the red cells were stored in a refrigerator at 4 degrees C for periods of up to 28 ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1992.32492263449.x

    authors: Myhre BA,Marcus CS

    更新日期:1992-05-01 00:00:00

  • Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

    abstract:BACKGROUND:Previous studies showed that Mirasol (Navigant Biotechnologies, Inc.) pathogen reduction technology (PRT) treatment resulted in an increase in platelet (PLT) glucose consumption and lactate production rates and decrease in pH in media during PLT storage. Increased glycolytic flux could result from damage to ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2005.04381.x

    authors: Li J,Lockerbie O,de Korte D,Rice J,McLean R,Goodrich RP

    更新日期:2005-06-01 00:00:00

  • Risk of chikungunya virus transmission associated with European travelers returning from southern Thailand (2008-2015).

    abstract:BACKGROUND:The impact of the spread of chikungunya virus (CHIKV) by autochthonous transmission and blood transfusion in nonendemic areas via travelers returning from CHIKV-affected locations is a concern. METHODS:We analyzed the risks of potential CHIKV importation and transfusion transmission from Thailand to Europe ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.15401

    authors: Appassakij H,Khuntikij P,Silpapojakul K,Promwong C,Rujirojindakul P,Suddeaugrai O,Chullasara A

    更新日期:2019-08-01 00:00:00

  • Improving platelet supply chains through collaborations between blood centers and transfusion services.

    abstract:BACKGROUND:Blood centers and hospital transfusion services are challenged with maintaining an adequate platelet (PLT) inventory to minimize the number of outdated units without risking a major shortage. A novel approach to inventory management was established at our institution through a collaboration between the Stanf...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2009.02236.x

    authors: Fontaine MJ,Chung YT,Rogers WM,Sussmann HD,Quach P,Galel SA,Goodnough LT,Erhun F

    更新日期:2009-10-01 00:00:00

  • A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.

    abstract::Current criteria for a reactive (positive) interpretation on hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) require > or = 1+ reactivity to at least two of the four HCV antigens present in the assay. Given that 5-1-1 is a subcomponent of c100-3, there is concern that donor samples reacting only with these...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1993.33193142316.x

    authors: Busch MP,Tobler L,Quan S,Wilber JC,Johnson P,Polito A,Steane E,Zola A,Bahl C,Nelles M

    更新日期:1993-01-01 00:00:00

  • Successful storage of RBCs for 9 weeks in a new additive solution.

    abstract:BACKGROUND:This study explored the effect of storing packed RBCs suspended in 200 mL of an alkaline, hypotonic, experimental additive solution (EAS 61). STUDY DESIGN AND METHODS:Packed RBC units prepared from RBCs collected from healthy donors in CPD were stored for 8 (n = 10) and 9 (n = 10) weeks under blood bank con...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.2000.40081007.x

    authors: Hess JR,Rugg N,Knapp AD,Gormas JF,Silberstein EB,Greenwalt TJ

    更新日期:2000-08-01 00:00:00

  • The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.

    abstract:BACKGROUND:Blood transfusion is the first-line treatment for patients with thalassemia and many sickle cell patients. However, cases of unregulated blood transfusion are shown to carry a high risk of alloimmunization to red blood cells (RBCs), which can lead to a hemolytic transfusion reaction and be fatal to patients....

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.15682

    authors: Hindawi S,Badawi M,Elfayoumi R,Elgemmezi T,Al Hassani A,Raml M,Alamoudi S,Gholam K

    更新日期:2020-02-01 00:00:00

  • Blood groups: the past 50 years.

    abstract::Since the first issue of TRANSFUSION in 1961, there has been a tremendous expansion in not only the number of blood group antigens identified but also in our knowledge of their biochemical basis, function, and more recently, associated DNA changes. As certain techniques became available, our ability to discover and el...

    journal_title:Transfusion

    pub_type: 历史文章,杂志文章

    doi:10.1111/j.1537-2995.2009.02456.x

    authors: Daniels G,Reid ME

    更新日期:2010-02-01 00:00:00

  • Current challenges for CAR T-cell therapy of acute myeloid leukemia.

    abstract::KEY IDEAS Chimeric antigen receptor (CAR) T-cell therapy has the potential to improve the dismal outcome of patients diagnosed with acute myeloid leukemia (AML). A major challenge for CAR T-cell therapy of AML patients is identifying leukemia-specific target antigens. Immune escape through down-regulation of target an...

    journal_title:Transfusion

    pub_type: 杂志文章,评审

    doi:10.1111/trf.15199

    authors: Sauer T,Rooney CM

    更新日期:2019-04-01 00:00:00

  • Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.

    abstract::The US Food and Drug Administration (FDA) held a workshop on red blood cell (RBC) product regulatory science on October 6 and 7, 2016, at the Natcher Conference Center on the National Institutes of Health (NIH) Campus in Bethesda, Maryland. The workshop was supported by the National Heart, Lung, and Blood Institute, N...

    journal_title:Transfusion

    pub_type:

    doi:10.1111/trf.14435

    authors: Vostal JG,Buehler PW,Gelderman MP,Alayash AI,Doctor A,Zimring JC,Glynn SA,Hess JR,Klein H,Acker JP,Spinella PC,D'Alessandro A,Palsson B,Raife TJ,Busch MP,McMahon TJ,Intaglietta M,Swartz HM,Dubick MA,Cardin S,Patel

    更新日期:2018-01-01 00:00:00

  • Prolonged platelet preservation by transient metabolic suppression.

    abstract:BACKGROUND:In this study whether metabolic suppression can be used to preserve platelet (PLT) function during prolonged storage was investigated. STUDY DESIGN AND METHODS:Washed human PLTs were incubated without glucose and with antimycin A to block energy generation. Metabolic suppressed PLTs (MSPs) were stored for 7...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2004.04022.x

    authors: Badlou BA,Ijseldijk MJ,Smid WM,Akkerman JW

    更新日期:2005-02-01 00:00:00